ULOQ [Study As­sess­ment]

posted by Ohlbe – France, 2017-10-30 15:10  – Posting: # 17953
Views: 5,639

Hi Helmut,

» Let’s assume that the subject with concentrations >ULOQ is observed in the last batch and we are already close to the validated long-term stability. Even if we revalidate with a higher dilution, we may exhaust the storage interval – resulting in unacceptable results as well. In such a case we have to exclude the subject.

If the storage interval is limited by the duration studied during validation (e.g. stability demonstrated for 30 days, still fine at the end): I would extend the validated period (always keep some extra stability samples in the freezer, just in case !). If the stab failed at the last time point: indeed in trouble. But I think that regulators would not see with a very positive eye the exclusion of the one subject with the highest Cmax in the whole study. Particularly if his Cmax was within range in the other period.


Complete thread:

 Admin contact
20,122 posts in 4,245 threads, 1,383 registered users;
online 14 (1 registered, 13 guests [including 9 identified bots]).
Forum time (Europe/Vienna): 13:32 CET

Genius is that which forces
the inertia of humanity to learn.    Henri Bergson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz